Download PDF
Synlett 2020; 31(11): 1083-1086
DOI: 10.1055/s-0040-1708021
letter
© Georg Thieme Verlag Stuttgart · New York

Practical Synthesis of the Fluorogenic Enzyme Substrate 4-Methylumbelliferyl α-l-Idopyranosiduronic Acid

Jiameng Tian
a   Key Laboratory of Organic Chemistry in Jiangxi Province, Institute of Organic Chemistry, Jiangxi Science & Technology Normal University, Nanchang 330013, P. R. of China   Email: dinghaixin_2010@163.com   Email: xiaoqiang@tsinghua.org.cn
,
Wenliang Ouyang
a   Key Laboratory of Organic Chemistry in Jiangxi Province, Institute of Organic Chemistry, Jiangxi Science & Technology Normal University, Nanchang 330013, P. R. of China   Email: dinghaixin_2010@163.com   Email: xiaoqiang@tsinghua.org.cn
,
Yanling He
b   Beijing Landbridge Technology Co., Ltd., No. 3, Gaobeidian North Road, Chaoyang District, Beijing, P. R. of China
,
Qianqian Ning
a   Key Laboratory of Organic Chemistry in Jiangxi Province, Institute of Organic Chemistry, Jiangxi Science & Technology Normal University, Nanchang 330013, P. R. of China   Email: dinghaixin_2010@163.com   Email: xiaoqiang@tsinghua.org.cn
,
Jiang Bai
a   Key Laboratory of Organic Chemistry in Jiangxi Province, Institute of Organic Chemistry, Jiangxi Science & Technology Normal University, Nanchang 330013, P. R. of China   Email: dinghaixin_2010@163.com   Email: xiaoqiang@tsinghua.org.cn
,
Haixin Ding∗
a   Key Laboratory of Organic Chemistry in Jiangxi Province, Institute of Organic Chemistry, Jiangxi Science & Technology Normal University, Nanchang 330013, P. R. of China   Email: dinghaixin_2010@163.com   Email: xiaoqiang@tsinghua.org.cn
,
Qiang Xiao  ∗
a   Key Laboratory of Organic Chemistry in Jiangxi Province, Institute of Organic Chemistry, Jiangxi Science & Technology Normal University, Nanchang 330013, P. R. of China   Email: dinghaixin_2010@163.com   Email: xiaoqiang@tsinghua.org.cn
› Author AffiliationsThis project was supported by the National Natural Science Foundation of China (Grant No. 21676131, 21462019), the Bureau of Science & Technology of Jiangxi Province (Grant No. 20143ACB20012), the Education Department of Jiangxi Province (Grant No.170673), and the Jiangxi Science & Technology Normal University (Doctor Startup Fund 2018BSQD022).
Further Information

Publication History

Received: 03 March 2020

Accepted after revision: 27 March 2020

Publication Date:
17 April 2020 (online)

    Permissions and Reprints All articles of this category


Abstract

A practical and concise synthesis of 4-methylumbelliferyl α-l-idopyranosiduronic acid, a fluorogenic enzyme substrate diagnostic for α-l-iduronidase, was accomplished. It features successive radical bromination and radical reduction of easily accessible methyl 4-methyl­umbelliferyl-2,3,4-tri-O-acetyl-β-d-glucouronate in four steps with 28% overall yield.

Key words

α-l-Iduronidase - 4-methylumbelliferyl α-l-idopyranosiduronic acid - radical reduction - radical bromination - fluorogenic enzyme substrate - synthesis

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/s-0040-1708021.
  • Supporting Information
 

  • References and Notes

    • 1a Clements PR, Muller V, Hopwood JJ. Eur. J. Biochem. 1985; 152: 29
      CrossrefPubMed
    • 1b Freeman C, Hopwood JJ. Biochem. J. 1992; 282: 899
      CrossrefPubMed
    • 3a Archer LD, Langford-Smith KJ, Bigger BW, Fildes JE. J. Inherited Metab. Dis. 2014; 37: 1
      PubMed
    • 3b Parini R, Deodato F, Di RM, Lanino E, Locatelli F, Locatelli F, Messina C, Rovelli A, Scarpa M. Orphanet J. Rare Dis. 2017; 12: 112
      CrossrefPubMed
    • 4a Scott HS, Bunge S, Gal A, Clarke LA, Morris CP, Hopwood JJ. Hum. Mutat. 1995; 6: 288
      CrossrefPubMed
    • 4b Langereis EJ, van Vlies N, Wijburg FA. Expert Opin. Orphan Drugs 2015; 3: 307
    • 5a Burke HM, Gunnlaugsson T, Scanlan EM. Chem. Commun. 2015; 51: 10576
      CrossrefPubMed
    • 5b Turunen P, Rowan AE, Blank K. FEBS Lett. 2014; 588: 3553
      CrossrefPubMed
    • 5c Grimm JB, Heckman LM, Lavis LD. Prog. Mol. Biol. Transl. Sci. 2013; 113: 1
      PubMed
    • 5d Wysocki LM, Lavis LD. Curr. Opin. Chem. Biol. 2011; 15: 752
      CrossrefPubMed
    • 6a Utterworth J, Broadhead DM. J. Inherited Metab. Dis. 1979; 2: 71
      CrossrefPubMed
    • 6b Hopwood JJ, Muller V, Smithson A, Baggett N. Clin. Chim. Acta 1979; 92: 257
      CrossrefPubMed
    • 6c Butterworth J, Broadhead DM. J. Inherit. Metab. Dis. 1980; 2: 71
      PubMed
    • 6d Breier AC, Ce J, Mezzalira J, Daitx VV, Moraes VC, Goldim MP. S, Coelho JC. Clin. Biochem. 2017; 50: 431
      CrossrefPubMed
    • 6e Ou L, Herzog TL, Wilmot CM, Whitley CB. Mol. Genet. Metab. 2014; 111: 113
      CrossrefPubMed
    • 7a Srivastava RM, Hudson N, Seymour FR, Weissmann B. Carbohydr. Res. 1978; 60: 315
      Crossref
    • 7b Weissmann B. Methods Enzymol. 1978; 50: 141
      PubMed
    • 8a Voznyi YV, Kalicheva IS, Galoyan AA, Gusina NB. Bioorg. Khim. 1989; 15: 1411
    • 8b Voznyi YV, Kalicheva IS, Galoyan AA. Bioorg. Khim. 1987; 13: 1655
    • 9a Lu FC, Lico LS, Hung SC. ARKIVOC 2013; (ii): 13
    • 9b Lee J.-C, Chang SW, Liao CC, Chi FC, Chen CS, Wen YS, Wang CC, Kulkarni SS, Puranik R, Liu YH, Hung SC. Chemistry 2004; 10: 399
      CrossrefPubMed
  • 10 Tian JM, Ning QQ, Ding HX, Bai J, Xiao Q. Chin. J. Org. Chem. 2020; 40: 215
    Crossref
    • 11a Zulueta MM. L, Zhong YQ, Hung SC. Chem. Commun. 2013; 49: 3275
      CrossrefPubMed
    • 11b Lee JC, Chang SW, Liao CC, Chi FC, Chen CS, Wen YS, Wang CC, Kulkarni SS, Puranik R, Liu YH, Hung SC. Chem. Eur. J. 2004; 10: 399
      CrossrefPubMed
    • 11c Pellissier H. Org. Prep. Proced. Int. 2002; 34: 441
      Crossref
  • 12 Cheallaigh AN, Potter GT, Gardiner JM, Miller GJ. Org. Synth. 2016; 93: 200
    Crossref
    • 13a Mikula H, Matscheko D, Schwarz M, Hametner C, Froehlich J. Carbohydr. Res. 2013; 370: 19
      CrossrefPubMed
    • 13b Chen DZ, Wu T, Zhao Z, Lin XQ, Yang T, Yang J. J. Chem. Res. 2013; 37: 671
      Crossref
    • 14a Nasseri SA, Betschart L, Opaleva D, Rahfeld P, Withers SG. Angew. Chem. Int. Ed. 2018; 57: 11359
      CrossrefPubMed
    • 14b Anderson FB. Clin. Chim. Acta 1965; 12: 669
    • 15a Ferrier RJ, Furneaux RH. J. Chem. Soc., Perkin Trans. 1 1977; 1996
    • 15b Chiba T, Sinay P. Carbohydr. Res. 1986; 151: 379
      Crossref
    • 15c Somsak L, Ferrier RJ. Adv. Carbohydr. Chem. Biochem. 1991; 49: 37
      PubMed
    • 15d Yu HN, Furukawa J, Ikeda T, Wong CH. Org. Lett. 2004; 6: 723
      CrossrefPubMed
    • 16a Cao X, Lv Q, Li D, Ye H, Yan X, Yang X, Gan H, Zhao W, Jin L, Wang P, Shen J. Asian J. Org. Chem. 2015; 4: 899
      Crossref
    • 16b Mohamed S, Krenske EH, Ferro V. Org. Biomol. Chem. 2016; 14: 2950
      CrossrefPubMed
    • 16c Pawar NJ, Wang L, Higo T, Bhattacharya C, Kancharla PK, Zhang FM, Baryal K, Huo CX, Liu J, Linhardt RJ, Huang XF, Hsieh-Wilson LC. Angew. Chem. Int. Ed. 2019; 58: 18577
      CrossrefPubMed
  • 17 Characterization Data of Compound 13 Mp 89–91 °C; [α]D 25 –08.1 (c 0.068, CH2Cl2). 1H NMR (400 MHz, DMSO-d 6): δ = 7.75 (d, J = 8.8 Hz, 1 H, H-5), 7.16 (s, 1 H, H-8), 7.11 (d, J = 8.9 Hz, 1 H, H-6), 6.28 (s, 1 H, H-3), 6.02 (s, 1 H, H-1′), 5.16 (s, 1 H, H-3′), 5.04 (s, 2 H, H-2′, H-4′), 4.99 (s, 1 H, H-5′), 3.66 (s, 3 H, OCH3), 2.41 (s, 3 H, 4-CH3), 2.16 (s, 3 H, OAc), 2.10 (s, 3 H, OAc), 2.05 (s, 3 H, OAc). 13C NMR (101 MHz, DMSO-d 6): δ = 169.1 (OAc), 169.0 (C × 2, OAc), 167.3 (COOMe), 159.8 (C-2), 158.1 (C-7), 154.2 (C-9), 153.1 (C-4), 126.7 (C-5), 114.8 (C-10), 113.4 (C-6), 112.2 (C-3), 103.8 (C-8), 95.2 (C-1′), 67.5 (C-5′), 66.8 (C-3′), 66.4(C-4′), 66.0 (C-2′), 52.3 (OCH3), 20.5 (C × 2, OAc), 20.3 (OAc), 18.0 (4-CH3). HRMS (ESI+): m/z calcd for C23H25O12 [M + H]+: 493.1341; found: 493.1346.
  • 18 Characterization Data of Compound 14 Mp 119–121 °C; [α]D 25 –111.7 (c 0.081, CH3OH). 1H NMR (400 MHz, DMSO-d 6): δ = 7.73 (d, J = 8.5 Hz, 1 H, H-5), 7.07–7.04 (m, 2 H, H-8, H-6), 6.26 (s, 1 H, H-3), 5.70 (d, J = 4.9 Hz, 1 H, H-1′), 5.57 (d, J = 5.8 Hz, 1 H, 2′-OH), 5.38–5.36 (m, 2 H, 3′-OH, 4′-OH), 4.65 (d, J = 4.3 Hz, 1 H, H-5′), 3.82–3.78 (m, 1 H, H-4′), 3.67–3.63 (m, 4 H, H-3′, COOMe), 3.58–3.53 (m, 1 H, H-2′), 2.40 (s, 3 H, 4-CH3). 13C NMR (101 MHz, DMSO-d6 ): δ = 170.0 (COOMe), 160.0 (C-2), 159.6 (C-7), 154.3 (C-9), 153.2 (C-4), 126.6 (C-5), 114.2 (C-10), 113.3 (C-6), 111.8 (C-3), 103.3 (C-8), 99.0 (C-1′), 71.8 (C-5′), 71.4 (C-3′), 70.7 (C-2′), 70.0 (C-4′), 51.7 (OCH3), 18.1 (4-CH3). HRMS (ESI+): m/z calcd for C17H19O9 [M + H]+: 367.1024; found: 367.1029.
  • 19 Characterization Data of 4-Methylumbelliferyl α-l-Idopyranosiduronic Acid (1) Mp 205–207 °C; [α]D 25 –38.3 (c 0.021, CH3OH). 1H NMR (400 MHz, DMSO-d 6): δ = 7.87(s, 1 H, H-8), 7.65 (d, J = 8.8 Hz, 1 H, H-5), 7.34 (dd, J = 8.8, 2.4 Hz, 1 H, H-6), 6.21 (s, 1 H, H-3), 5.51 (d, J = 7.0 Hz, 1 H, 2′-OH), 5.19 (d, J = 4.9 Hz, 1 H, H-1′), 4.96 (d, J = 3.8 Hz, 1 H, 3′-OH), 3.99 (d, J = 6.2 Hz, 1 H, H-3′), 3.25–3.17 (m, 3 H, H-2′, H-4′, H-5′), 2.40 (s, 3 H, 4-CH3). 13C NMR (101 MHz, DMSO-d 6): δ = 172.1 (COOH), 160.8 (C-2), 160.4 (C-7), 154.6 (C-9), 153.4 (C-4), 126.0 (C-5), 113.6 (C × 2, C-10, C-6), 111.3 (C-3), 103.6 (C-8), 97.3 (C-1′), 74.4 (C-5′), 73.1 (C-3′), 72.5 (C-4′), 71.1 (C-2′), 18.1 (4-CH3). HRMS (ESI+): m/z calcd for C16H17O9 [M + H]+: 353.0867; found: 353.0868.